etoposide has been researched along with Primary Immunodeficiency Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohgaki, M; Bohgaki, T; Bristow, R; Cheung, P; El Ghamrasni, S; Eldin, MS; Guturi, KKN; Hakem, A; Hakem, R; Jeon, J; Kumareswaran, R; Ng, D; Patel, P; Raught, B; Srikumar, T; Stewart, GS | 1 |
1 other study(ies) available for etoposide and Primary Immunodeficiency Diseases
| Article | Year |
|---|---|
RNF168 and USP10 regulate topoisomerase IIα function via opposing effects on its ubiquitylation.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chromosome Segregation; Craniofacial Abnormalities; DNA Topoisomerases, Type II; DNA, Catenated; Drug Resistance, Neoplasm; Etoposide; Fibroblasts; Gene Knockdown Techniques; HEK293 Cells; Humans; Immunologic Deficiency Syndromes; Learning Disabilities; Mice; Mutagenesis, Site-Directed; Neoplasms; Poly-ADP-Ribose Binding Proteins; Primary Immunodeficiency Diseases; Proteomics; RNA, Small Interfering; Topoisomerase II Inhibitors; Ubiquitin Thiolesterase; Ubiquitin-Protein Ligases; Ubiquitination | 2016 |